| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve Allocation of Income and Absence of Dividends | For |
| O.4 | Approve Transaction with Credit Agricole CIB RE: Acquisition of 32,953 Preferred C Shares | For |
| O.5 | Elect Marie-Claire Daveu as Director | For |
| O.6 | Elect Pierre Cambefort as Director | Oppose |
| O.7 | Elect Pascal Lheureux as Director | Oppose |
| O.8 | Elect Philippe de Waal as Director | Oppose |
| O.9 | Reelect Caroline Catoire as Director | Oppose |
| O.10 | Reelect Laurence Dors as Director | Oppose |
| O.11 | Reelect Francoise Gri as Director | For |
| O.12 | Reelect Catherine Pourre as Director | For |
| O.13 | Reelect Daniel Epron as Director | Oppose |
| O.14 | Reelect Gerard Ouvrier-Buffet as Director | Oppose |
| O.15 | Approve Remuneration Policy of Chair of the Board | For |
| O.16 | Approve Remuneration Policy of CEO | Abstain |
| O.17 | Approve Remuneration Policy of Vice-CEO | Abstain |
| O.18 | Approve Remuneration Policy of Directors | For |
| O.19 | Approve Compensation of Dominique Lefebvre, Chair of the Board | For |
| O.20 | Approve Compensation of Philippe Brassac, CEO | For |
| O.21 | Approve Compensation of Xavier Musca, Vice-CEO | For |
| O.22 | Approve Compensation Report of Corporate Officers | For |
| O.23 | Approve the Aggregate Remuneration Granted in 2019 to Senior Management, Responsible Officers and Regulated Risk-Takers | Abstain |
| O.24 | Fix Maximum Variable Compensation Ratio for Executives and Risk Takers | For |
| O.25 | Authorise Share Repurchase | Oppose |
| E.26 | Amend Article 11 of Bylaws Re: Board Composition | For |
| E.27 | Amend Articles 14 and 19 of Bylaws to Comply with Legal Changes | For |
| E.28 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 4.3 Billion | For |
| E.29 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 870 Million | Oppose |
| E.30 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 870 Million | Oppose |
| E.31 | Authorise the Board to Increase the Number of Shares Issued in case of Exceptional Demand | Oppose |
| E.32 | Approve Issue of Shares for Contribution in Kind | For |
| E.33 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights | Oppose |
| E.34 | Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 28-32 and 36-37 at EUR 4.3 Billion | For |
| E.35 | Authorize Capitalization of Reserves of Up to EUR 1 Billion for Bonus Issue or Increase in Par Value | For |
| E.36 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Oppose |
| E.37 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of the Group's Subsidiaries | Oppose |
| E.38 | Authorise Cancellation of Treasury Shares | For |
| E.39 | Authorize up to 0.75 Percent of Issued Capital for Use in Restricted Stock Plans with Performance Conditions Attached | Oppose |
| E.40 | Authorize Filing of Required Documents/Other Formalities | For |
